Genetic Heterogeneity in Patients with Multiple Neoplastic Lung Lesions: A Report of Three Cases
Authors:
- Mariëlle I. Gallegos RuizMRMariëlle I. Gallegos Ruiz
- Hester van CruijsenHCHester van Cruijsen
- Egbert F. SmitESEgbert F. Smit
- Katrien GrünbergKGKatrien Grünberg
- Gerrit A. MeijerGMGerrit A. Meijer
- José A. RodriguezJRJosé A. Rodriguez
- Bauke YlstraBYBauke Ylstra
- Giuseppe GiacconeGGGiuseppe Giaccone
- 1 January 2007
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 2 (1) , 12-21
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Predictive Factors for Outcome in a Phase II Study of Gefitinib in Second-Line Treatment of Advanced Esophageal Cancer PatientsJournal of Clinical Oncology, 2006
- Array comparative genomic hybridization and its applications in cancerNature Genetics, 2005
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Comparative genomic hybridisation as a supportive tool in diagnostic pathologyJournal of Clinical Pathology, 2003
- Determination of the Molecular Relationship Between Multiple Tumors Within One Patient Is of Clinical ImportanceJournal of Clinical Oncology, 2002
- Risk of a new primary cancer among patients with lung cancer of different histological typesEuropean Journal of Cancer, 2001
- Second Cancers Occurring in Patients With Early Stage Non–Small-Cell Lung Cancer Treated With Chest Radiation Therapy AloneJournal of Clinical Oncology, 2001
- Second Lung Cancers in Patients After Treatment for an Initial Lung CancerJNCI: Journal of the National Cancer Institute, 1998